• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ULTRAFLEX ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ULTRAFLEX ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL Back to Search Results
Model Number M00513730
Device Problems Activation, Positioning or Separation Problem (2906); Difficult to Advance (2920); Appropriate Term/Code Not Available (3191)
Patient Problems No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/15/2020
Event Type  malfunction  
Manufacturer Narrative
(b)(4).The device has not been received for analysis; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientifc corporation on october 23, 2020 that an ultraflex esophageal ng distal release covered stent was to be implanted in the middle of the esophagus to treat an advanced esophageal cancer during a stent placement procedure performed on (b)(6) 2020.According to the complainant, during the procedure, the stent was advanced through the guidewire and noticed that the tip of the delivery system was partially deployed and it was difficult to pass through the pharynx.The stent was removed from the patient partially covered by the stent deployment suture and the procedure was not completed due to device availability.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Manufacturer Narrative
Block h6: medical device problem code a27 is being used to capture the reportable issue of aborted/cancelled procedure.Block h10: an ultraflex esophageal ng distal release covered stent and delivery system were received for analysis.The stent was received partially deployed.Visual inspection was performed and it was noted that the shaft was kinked.No other issues were noted to the stent and delivery system.The reported event of stent partially deployed was confirmed; however, the reported event of delivery system difficult to advance could not be confirmed as this failure occurred during the procedure and is not possible to replicate in the laboratory of analysis.The investigation concluded that the reported events and the observed failure were likely due to factors encountered during the procedure.It is possible that the technique used by the user during the deployment of the stent caused the kink in the shaft.Furthermore, the kink in the shaft could have caused the difficulty to advance the delivery system in the pharynx which resulted in the removal of a partially deployed stent.Therefore, a review and analysis of all available information indicated the most probable cause is adverse event related to the procedure.A review of the manufacturing documentation for this device revealed that no anomalies or deviations related to the event occurred during manufacturing.A labeling review was performed and, from the information available, this device was used per the instructions for use (ifu) / product label.
 
Event Description
It was reported to boston scientific corporation on october 23, 2020 that an ultraflex esophageal ng distal release covered stent was to be implanted in the middle of the esophagus to treat an advanced esophageal cancer during a stent placement procedure performed on (b)(6) 2020.According to the complainant, during the procedure, the stent was advanced through the guidewire and noticed that the tip of the delivery system was partially deployed and it was difficult to pass through the pharynx.The stent was removed from the patient partially covered by the stent deployment suture and the procedure was not completed due to device availability.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAFLEX ESOPHAGEAL NG
Type of Device
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
MDR Report Key10842689
MDR Text Key226077760
Report Number3005099803-2020-05331
Device Sequence Number1
Product Code ESW
UDI-Device Identifier08714729716150
UDI-Public08714729716150
Combination Product (y/n)N
PMA/PMN Number
K091816
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 08/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/03/2021
Device Model NumberM00513730
Device Catalogue Number1373
Device Lot Number0024371560
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/29/2021
Initial Date Manufacturer Received 10/23/2020
Initial Date FDA Received11/16/2020
Supplement Dates Manufacturer Received07/13/2021
Supplement Dates FDA Received08/04/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age83 YR
Patient Weight70
-
-